REGENERON PHARMACEUT

REGN
Delayed Quote. Delayed  - 12/03 04:00:00 pm
498.84USD -1.25%

Turn to zoom
Prev.505.1300
Open505.2000
High509.5400
Low497.1200
Volume966 018
Latest news
22h ago
1d ago
2d ago
3d ago
Chart REGENERON PHARMACEUTICALS
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBullish
Resistance544589644
Spread/Res.-8,0%-15%-22%
Spread/Supp.5,3%11%6,4%
Support475452470
Financials
Sales 2020 8 537 M - -
Net income 2020 3 189 M - -
Net cash 2020 5 499 M - -
P/E ratio 2020 17,9x
Yield 2020 -
Capitalization 53 314 M 53 314 M -
EV / Sales 2020 5,60x
EV / Sales 2021 4,28x
Nbr of Employees 8 314
Free-Float 83,3%
Company
Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:
- sales of products (61.5%);
- supply of collaborative services (33.3%): working with Sanofi...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-12-02 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 666,80 $
Last Close Price 505,13 $
Spread / Highest target 57,0%
Spread / Average Target 32,0%
Spread / Lowest Target -1,02%